Icon-twitter-x Facebook-f

News

I Peace’s Cell Manufacturing Facility “Peace Engine-Kyoto”now registered as U.S. FDA Drug Establishment

•
January 26, 2022
•
Press

[Summary of Research]Anti-cancer therapeutic potential of tumoricidal T cells regenerated from tumor-infiltrating lymphocyte-derived iPS cells

•
October 19, 2021
•
Other

Koji Tanabe, CEO of I Peace, Inc.
honored by World Biz Magazine with
the “ Top 100 Innovation CEO” Award

•
September 22, 2021
•
Press

Stem Cells for Everyone: I Peace expands its clinical-grade iPSC banking service leveraging mass manufacturing capability

•
September 7, 2021
•
Press

[Summary of Research]The iPSC-based cancer vaccine prevents tumor growth in pancreatic cancer

•
July 9, 2021
•
Other

I Peace’s cell manufacturing facility “Peace Engine Kyoto” receives third-party certification as US cGMP compliant: the facility now meets the standard
for both the US and Japanese markets

•
May 25, 2021
•
Press

[Summary of Research]Successful reconstruction of a three-Dimensional structure resembling a human embryo from iPS cells

•
May 5, 2021
•
Other

[Summary of Research]Artificially cultured brains mature much like infant brains

•
March 30, 2021
•
Other

I Peace in the News – the Nikkei March 22, 2021

•
March 22, 2021
•
Media

[Summary of Research]Autologous transplantation of iPS cell-derived dopaminergic neurons alleviates motor and depressive behaviors in Parkinson’s model monkeys

•
March 19, 2021
•
Other

Reach out to us to learn more

Contact Us

Copyright © I Peace
All rights reserved

Icon-twitter-x Facebook-f
I Peace has obtained a Privacy Mark

Copyright © I Peace  All rights reserved